Health Care [ 4/12 ] | Biotechnology [ 15/73 ]
NYSE MKT | Common Stock
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.
Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells.
The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 27, 25 | -0.27 Increased by +23.94% | -0.19 Decreased by -42.11% |
| Aug 11, 25 | -0.18 Increased by +64.00% | -0.25 Increased by +28.00% |
| May 9, 25 | -0.16 Increased by +65.22% | -0.18 Increased by +11.11% |
| Mar 24, 25 | -0.32 Increased by +20.00% | -0.35 Increased by +8.57% |
| Nov 6, 24 | -0.35 Increased by +1.39% | -0.47 Increased by +24.47% |
| Aug 19, 24 | -0.50 Decreased by -42.86% | -0.41 Decreased by -20.48% |
| May 14, 24 | -0.46 Decreased by -21.05% | -0.39 Decreased by -17.95% |
| Mar 21, 24 | -0.40 Increased by +6.98% | -0.39 Decreased by -2.56% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by N/A% | -8.90 M Decreased by -225.41% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -5.35 M Increased by +39.78% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by N/A% | -4.52 M Increased by +44.01% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -3.57 M Increased by +42.91% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.74 M Increased by +43.89% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -8.88 M Decreased by -96.29% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -8.07 M Decreased by -95.96% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -6.26 M Decreased by -22.27% | Decreased by N/A% Decreased by N/A% |